ASHDOD, Israel, November 30 /PRNewswire-FirstCall/ -- Healthcare Technologies, Ltd. , today announced unaudited results for the third quarter and nine months ended September 30, 2004.
Revenues for the first nine months of 2004 were $8.6 million, compared to $9.4 million for the first nine months of 2003. The gross profit for the first nine months was $3.1 million versus $3.5 million for the same period in 2003. The operating loss for such period was ($0.03) million compared to a loss of $(0.4) million last year. The net profit for the period was $0.01 million, or $0.0 per share, versus a net loss of ($0.3) million, or $(0.04) per share for same period last year.
Revenues for the third quarter of 2004 were $2.8 million, as compared to $2.4 million for the corresponding quarter last year. The third quarter gross profit was $1.0 million, as compared to $1.1 million in the third quarter of 2003. The net loss for the quarter was $(0.1) million, compared to a net loss of ($0.3) million, or ($0.04) per share for the third quarter of last year.
Shareholders' equity on September 30, 2004 was $2.6 million, compared to US$2.4 million on December 31, 2003. Cash and equivalents were $0.8 million compared to $1.4 million on December 31, 2003. Current assets net of current liabilities as of September 30, 2004, are $3.3 million versus $2.8 million on December 31, 2003.
About Healthcare Technologies
Healthcare Technologies through it subsidiaries Savyon Diagnostics Ltd., Gamidor Diagnostics (1984) Ltd. and Danyel Biotech Ltd., specializes in development, manufacturing and marketing of clinical diagnostic test kits and provides services and tools to diagnostic and biotech research professionals in laboratory and point of care sites worldwide.
Healthcare Technologies, Ltd.
Condensed Consolidated Statement of Operations
(U.S. Dollars in Thousands, Except Profit Loss Per Share Information)
Three Months Nine Months Year Ended
Ended Ended
09/30/04 09/30/03 09/30/04 09/30/03 12/31/03
Sales $2,857 $2,447 $8,645 $9,439 $12,412
Gross profit $975 $1,105 $3,132 $3,495 $4,772
Net profit $(134) $(213) $10 $(337) $(523)
(Loss)
Profit (Loss) per
share $(0.02) $(0.03) $0.00 $(0.04) $(0.07)
Weighted average
number of shares
and share
equivalents
outstanding
(in Thousands) 7,649 7,644 7,649 7,644 7,644
Safe Harbor: This press release contains certain forward looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward looking statement made by or on behalf of Healthcare Technologies Ltd. Readers are referred to the documents filed by the company with the Securities Exchange Commission, specifically the most recent report on Form 20F that identifies important risks which could cause actual results to differ from those contained in the forward looking statements.
Contact: Moshe Reuveni CEO +972-544-243-649
Healthcare Technologies Ltd.CONTACT: Moshe Reuveni, CEO, +972-544-243-649